Search for: "Genentech, Inc." Results 121 - 140 of 469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2007, 2:10 pm
Supreme Court's 8-1 ruling in favor of MedImmune (MedImmune, Inc. v. [read post]
20 Dec 2021, 8:42 am by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007) (licensee standing for declaratory judgment action); Blonder-Tongue Laboratories, Inc. v. [read post]
24 May 2009, 10:58 pm
In the case IN RE GENENTECH, INC. and BIOGEN IDEC INC., the petitioners sought, and obtained, a writ of mandamus to move the patent case from ED Texas to ND California. [read post]
9 Apr 2009, 12:34 pm
Due To Link With Fatal Brain Infection, Progressive Multifocal Leukoencephalopathy (PML) (Posted by Tom Lamb at DrugInjuryWatch.com) On April 8, 2009 Genentech Inc. -- which was just acquired by Roche Holding AG in March 2009 -- issued a press release announcing "a phased voluntary withdrawal of psoriasis drug Raptiva ® (efalizumab) from the U.S. market"  due to its link to a brain infection, progressive multifocal leukoencephalopathy (PML). [read post]
30 Jan 2009, 9:58 pm
Roche Seeks Hostile Takeover of Genentech Roche has indicated that it will turn to Genentech shareholders in an attempt to complete its desired purchase of the 44% of Genentech it does not own (see N.Y. [read post]
2 Jun 2020, 1:50 pm by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007), the Supreme Court opened the door to provide a licensee in good standing easier access to the courts. [read post]
20 Apr 2009, 10:30 pm
Genentech, Inc.), at least part of the Court's reasoning has been an attempt to prevent the Federal Circuit from developing and enforcing "bright line"... [read post]
17 Feb 2016, 12:19 am
Hoffmann-La Roche AG and Genentech Inc. [2016] EWHC 188 (Pat) come across her desk a few weeks ago. [read post]
17 Apr 2009, 5:21 pm
Genentech, Inc. made known on April 8, 2009 the phased voluntary removal of the psoriasis drug Raptiva (efalizumab) from the United States market. [read post]
5 Apr 2010, 9:29 am
Genentech set the stage for declaratory judgment actions at the sound of a snort from a patent holder. [read post]